Physician profile
Robert A Fleury
NPI 1467495903
$1,344.83
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $240 · 2021: $14.78 · 2022: $18.83.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $353.94 | 2019-2020 | |
| Alkermes, INC. | $211.20 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $102.19 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $100.81 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $91.79 | 2019-2021 | |
| Shire North American Group INC | $80.10 | 2019 | |
| Indivior INC. | $74.73 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $68.96 | 2019-2020 | |
| Allergan, INC. | $66.44 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $53.98 | 2019 | |
| Ironshore Pharmaceuticals INC. | $47.60 | 2019 | |
| Lundbeck LLC | $23.56 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $18.83 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.64 | 2019 | |
| Neuronetics, INC. | $13.31 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $11.41 | 2020 | |
| Acadia Pharmaceuticals INC | $11.34 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fleury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.